“Omalizumab Improves Angioedema-Related Quality of Life Impariment in Patients With Chronic Idiopathic Chronic Spontaneous Urticaria: Results from the X-Act Study”. 2018. SKIN The Journal of Cutaneous Medicine 2 (S1): S53. https://doi.org/10.25251/skin.2.supp.53.